ZVSA
USDZyVersa Therapeutics Inc. Common Stock
$0.145+0.009 (6.618%)
即時價格
Healthcare
生物科技
美國
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$0.136
最高
$0.145
最低
$0.136
交易量
0.00M
公司基本面
市值
1.2M
行業
生物科技
國家
United States
交易統計
平均交易量
0.04M
交易所
OQB
貨幣
USD
52週範圍
最低 $0.11當前 $0.145最高 $1.95
相關新聞
GlobeNewswire
ZyVersa Therapeutics Highlights Data Reinforcing the Potential of Inflammasome Inhibitors to Attenuate Progression of Type 2 Diabetes and Improve Associated Long-term Cardiovascular Outcomes
Type 2 diabetes (T2DM), affecting more than 530 million worldwide, is a metabolic disease often coupled with cardiovascular complications including coronary artery disease, heart failure, and stroke.Cardiovascular
查看更多
GlobeNewswire
ZyVersa Therapeutics Highlights Lipidomic Data in Alport Syndrome and DKD Reinforcing the Need for Drugs to Attenuate Damaging Renal Lipid Accumulation to Mitigate Disease Progression
ZyVersa is developing Cholesterol Efflux Mediator™ VAR 200 to mediate removal of damaging excess cholesterol and other lipids from the kidneys' filtration system. VAR 200 directly removes lipids from kidney cells,
查看更多
相關股票
保持更新
設定價格提醒，獲取AI分析更新和即時市場新聞。